| 1G | 1st generation |
| 2G | 2nd generation |
| 3G | 3rd generation |
| 4G | 4th generation |
| AAV | Adeno-associated virus |
| ACT | Adoptive cell therapy |
| AICD | Activation induced cell death |
| ALL | Acute lymphoblastic leukemia |
| APCs | Antigen presenting cells |
| BCAP | B cell adaptor for phosphoinositide 3-kinase |
| BCMA | B cell maturation antigen |
| BCR | B cell receptor |
| BET | Bromodomain and extra-terminal motif |
| CAR | Chimeric antigen receptor |
| CLL | Chronic lymphocytic leukemia |
| CTLA-4 | Cytotoxic T-lymphocyte-associated Protein 4 |
| DCs | Dendritic cells |
| DLBCL | Diffuse large B cell lymphoma |
| EMA | European Medicines Agency |
| FDA | Food and Drug Administration |
| GMP | Good manufacturing practice |
| HLA | Human leukocyte antigen |
| ICOS | Inducible T cell costimulator |
| IL | Interleukin |
| ITAM | Immunoreceptor tyrosine-based activation motif |
| NHL | Non-Hodgkin lymphoma |
| LAG-3 | Lymphocyte-activation gene-3 |
| PB | Peripheral blood |
| PBMC | Peripheral blood mononuclear cells |
| PD-1 | Programmed cell death protein 1 |
| PI3K | Phosphoinositide 3-kinase |
| PMBCL | Primary mediastinal B cell lymphoma |
| r/r | relapsed/refractory |
| scFv | Single chain variable fragment |
| TAA | Tumor-associated antigen |
| TCR | T cell receptor |
| TCM cell | Central memory-like T cell |
| TEff cell | Effector-like T cell |
| TEM cell | Effector memory-like T cell |
| TGFβ | Transforming growth factor β |
| Th cell | T helper cell |
| TILs | Tumor-infiltrating lymphocytes |
| TIM-3 | T cell immunoglobulin and mucin-domain containing-3 |
| TN cell | Naïve-like T cell |
| TM | Transmembrane |
| TRAC | T cell receptor α constant |
| Treg cell | Regulatory T cell |
| TRUCK | T cells redirected for universal cytokine killing |
| TSCM cell | Stem cell memory-like T cell |
| VIP | Vasoactive intestinal peptide |